Olopade OI - Search Results

1

Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.

Zhang B, Fackenthal JD, Niu Q, Huo D, Sveen WE, DeMarco T, Adebamowo CA, Ogundiran T, Olopade OI. Zhang B, et al. Among authors: olopade oi. Fam Cancer. 2009;8(1):15-22. doi: 10.1007/s10689-008-9205-9. Epub 2008 Aug 5. Fam Cancer. 2009. PMID: 18679828

2

Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.

Grushko TA, Blackwood MA, Schumm PL, Hagos FG, Adeyanju MO, Feldman MD, Sanders MO, Weber BL, Olopade OI. Grushko TA, et al. Among authors: olopade oi. Cancer Res. 2002 Mar 1;62(5):1481-8. Cancer Res. 2002. PMID: 11888924

3

BRCA2 T2722R is a deleterious allele that causes exon skipping.

Fackenthal JD, Cartegni L, Krainer AR, Olopade OI. Fackenthal JD, et al. Among authors: olopade oi. Am J Hum Genet. 2002 Sep;71(3):625-31. doi: 10.1086/342192. Epub 2002 Jul 19. Am J Hum Genet. 2002. PMID: 12145750 Free PMC article.

4

Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.

Huo Z, Giger ML, Olopade OI, Wolverton DE, Weber BL, Metz CE, Zhong W, Cummings SA. Huo Z, et al. Among authors: olopade oi. Radiology. 2002 Nov;225(2):519-26. doi: 10.1148/radiol.2252010845. Radiology. 2002. PMID: 12409590

5

Breast cancer genetics in African Americans.

Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Olopade OI, et al. Cancer. 2003 Jan 1;97(1 Suppl):236-45. doi: 10.1002/cncr.11019. Cancer. 2003. PMID: 12491487 Free article. Review.

6

Racial differences in genetic factors associated with breast cancer.

Ademuyiwa FO, Olopade OI. Ademuyiwa FO, et al. Among authors: olopade oi. Cancer Metastasis Rev. 2003 Mar;22(1):47-53. doi: 10.1023/a:1022259901319. Cancer Metastasis Rev. 2003. PMID: 12716036 Review.

7

Obesity and height in urban Nigerian women with breast cancer.

Adebamowo CA, Ogundiran TO, Adenipekun AA, Oyesegun RA, Campbell OB, Akang EU, Rotimi CN, Olopade OI. Adebamowo CA, et al. Among authors: olopade oi. Ann Epidemiol. 2003 Jul;13(6):455-61. doi: 10.1016/s1047-2797(02)00426-x. Ann Epidemiol. 2003. PMID: 12875805

8

MYC is amplified in BRCA1-associated breast cancers.

Grushko TA, Dignam JJ, Das S, Blackwood AM, Perou CM, Ridderstråle KK, Anderson KN, Wei MJ, Adams AJ, Hagos FG, Sveen L, Lynch HT, Weber BL, Olopade OI. Grushko TA, et al. Among authors: olopade oi. Clin Cancer Res. 2004 Jan 15;10(2):499-507. doi: 10.1158/1078-0432.ccr-0976-03. Clin Cancer Res. 2004. PMID: 14760071

9

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.

Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI. Nanda R, et al. Among authors: olopade oi. JAMA. 2005 Oct 19;294(15):1925-33. doi: 10.1001/jama.294.15.1925. JAMA. 2005. PMID: 16234499

10

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, Xu J, Fackenthal J, Tretiakova M, Das S, Olopade OI. Wei M, et al. Among authors: olopade oi. Cancer Res. 2005 Dec 1;65(23):10692-9. doi: 10.1158/0008-5472.CAN-05-1277. Cancer Res. 2005. PMID: 16322213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters